Thomas Matthew Habermann
机构：Mayo Clinic, Deutsche Telekom (Austria), WinnMed, Mayo Clinic in Arizona · ORCID：0000-0003-3532-9132
发表论文 1086 篇 · 总被引 40194 次 · h-index 99
代表论文
- FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma (2025 · Journal of Clinical Oncology · 被引 1)
- Malignant B-cell States Orchestrate Spatially Organized Immune Ecosystems in B-cell Lymphomas (2026 · Research Square)
- Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk Loci (2026 · Circulation Genomic and Precision Medicine)
- Treatment patterns and outcomes for second-line therapy in large B-cell lymphoma: results from the LEO CReWE study (2026 · Blood Cancer Journal)
- No Association of Prior Administration of Selected Vaccines with Lymphoma Prognosis (2026 · Cancer Epidemiology Biomarkers & Prevention)
- Immunity Gone Viral (2026 · Neurology Neuroimmunology & Neuroinflammation)